Test Price
450 AED✅ Home Collection Available
Immunohistochemistry CD45 (Leukocyte Common Antigen, LCA) Test in UAE – 450 AED – DHA Licensed
Executive Summary & Core Metrics
Clinical Confidence, Delivered to Your Doorstep
- 99.9% Diagnostic Sensitivity – ISO‑accredited IHC processing on FFPE tissue with automated stainers and validated antibody clones.
- Secure Medical Courier Solid Tissue Specimen Retrieval – ISO‑certified cold‑chain logistics for FFPE block or biopsy slide submission, available daily 8 AM – 11 PM.
- Telephonic Post‑Test Clinical Guidance – Complimentary result interpretation support with a senior pathologist.
- Direct Insurance Billing – Verify instantly via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The CD45 (LCA) Immunohistochemistry test is a tissue‑based biomarker assay that differentiates haematolymphoid malignancies from poorly differentiated non‑lymphoid tumours. This pan‑leukocyte antibody is applied to formalin‑fixed paraffin‑embedded (FFPE) tumour tissue, enabling direct microscopic correlation. Results are available within 5–7 working days, providing essential diagnostic clarity for oncologists and surgical pathologists.
| Feature | CD45 IHC Test (FFPE) | Flow Cytometry (Liquid Sample) |
|---|---|---|
| Diagnostic Sensitivity | 99.9% on FFPE tissue | 85–92% (live cell suspension) |
| Methodology | Immunohistochemistry (monoclonal CD45Ab) | Flow cytometric immunophenotyping |
| Turnaround Time | 5 days (block) / 7 days (large complex) | 24–48 hours |
| Tissue Morphology | Preserved – enables direct microscopic correlation | Not evaluated |
| UAE Regulatory Status | DHA/MOHAP‑approved, ISO 9001:2015, PDPL‑compliant | Approved for liquid samples only |
Pre‑Test Requirements
- Submit tumour tissue in 10% formal‑saline or a formalin‑fixed paraffin‑embedded (FFPE) block at room temperature.
- Attach a copy of the original Histopathology report, exact site of biopsy, and complete clinical history.
- No drug or supplement restrictions are required for tissue collection; however, do not alter any prescribed therapy without physician approval.
Physician Insight & Safety Protocols
“As a DHA‑licensed specialist, I emphasise that the CD45 IHC result must always be correlated with the full haematoxylin‑eosin morphology and the patient’s clinical picture. No single marker stands alone—false‑negative or aberrant staining can occur in decalcified or poorly fixed samples.” — Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011.
Medication Advisory
Do not discontinue any prescribed medication (including corticosteroids or immunosuppressants) without explicit consultation with your treating oncologist. Abrupt cessation may alter disease activity and compromise diagnostic accuracy. Federal Decree-Law No. 4 of 2016 on Medical Liability governs all clinical safety and patient consent procedures.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Tissue with extensive necrosis (>50%), severe crush artefact, or fixation duration <6 hours in formalin.
- Exclusion: Specimen submitted in non‑formalin fixatives (Bouin’s, B5) may yield false‑negative CD45 staining.
- Seek immediate medical attention if you experience rapid tumour enlargement, uncontrollable pain, or acute haemorrhage—these may indicate an urgent oncological event unrelated to the test procedure.
Patient FAQ & Clinical Guidance
1. What does the CD45 IHC test diagnose, and how is it different from a blood test?
The CD45 Immunohistochemistry test identifies leukocyte‑derived malignancies and differentiates haematolymphoid neoplasms from poorly differentiated carcinomas. This method directly examines tumour tissue architecture, unlike a peripheral blood flow cytometry analysis that only profiles circulating cells.
2. How should I prepare for sample collection, and is home service available?
Organise the original histopathology report, biopsy site details, and clinical history along with the FFPE block. Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Secure Medical Courier Solid Tissue Specimen Retrieval is available daily from 8 AM to 11 PM across all UAE emirates.
3. How reliable are the results, and what should I do after receiving them?
Results achieve 99.9% diagnostic sensitivity when tissue fixation and processing meet DHA standards. A senior pathologist provides telephonic interpretation. Always discuss the report with your oncologist to integrate CD45 findings with other markers and imaging before making treatment decisions.
4. What risks are associated with the biopsy procedure itself?
Biopsy procedures carry inherent risks such as bleeding, infection, or pain at the site, which are managed by your healthcare team. The CD45 IHC test on the tissue sample does not introduce additional risks beyond standard pathology processing.
UAE Regulatory & Data Privacy Adherence
This service operates in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – safeguarding all patient health information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure digital health data handling.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – governing clinical safety and patient consent.
- All testing is performed under ISO 9001:2015 certification (INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry CD45 (Leukocyte Common Antigen, LCA) |
| Price (AED) | 450 |
| Turnaround Time | 5–7 working days |
| Sample Type / Matrix | Formalin-fixed paraffin-embedded (FFPE) tissue block or biopsy slides |
| Methodology Used | Immunohistochemistry (monoclonal CD45 antibody, Leica Bond III automated stainer) |
| ICD-10-CM Code | C96.9 (Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified) |
| LOINC Code | 10451-3 (Leukocyte common antigen [Interpretation] in Tissue by Immunohistochemistry) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians